1.Preface and Scope1
1.1.Report Objectives and Analytical Framework2
1.2.Study Period, Base Year, and Forecast Convention3
1.3.Definitions and Terminology (CBC, Differential, Reagent Rental)4
2.Research Methodology5
2.1.Primary Research: KOL Interviews and OEM Survey6
2.2.Secondary Research: SEC Filings, WHO, World Bank Health Data7
2.3.Forecast Model Assumptions and CAGR Derivation8
2.4.Data Triangulation and Validation Protocol9
3.Executive Summary10
3.1.Market Snapshot: USD 5.4B (2025) → USD 8.9B (2033) at 6.4% CAGR10
3.2.Key Findings by Segment Dimension12
3.3.Contrarian Observations and Analyst Calls15
3.4.Strategic Implications for OEMs, Investors, and Policymakers17